Therma Bright Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TBRIF research report →
Companywww.thermabright.com
Therma Bright Inc. engages in the development and sale of rapid COVID testing products, medical devices for pain management, devices to improve circulation, and devices for the cosmeceutical industry. The company's products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therapy device for pain relief without pain relieving medication; Venowave, a medical compression pump designed to treat and alleviate the symptoms associated with poor circulation; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings.
- CEO
- Roberto Fia
- IPO
- 2021
- HQ
- Toronto, ON, CA
Price Chart
Valuation
- Market Cap
- $2.03M
- P/E
- -0.85
- P/S
- 47.30
- P/B
- -1.84
- EV/EBITDA
- -0.83
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 22.11%
- Op Margin
- -1761.23%
- Net Margin
- -5884.33%
- ROE
- 420.68%
- ROIC
- 66.26%
Growth & Income
- Revenue
- $80.27K · 207.90%
- Net Income
- $-3,134,579 · -27.87%
- EPS
- $-0.06 · -616.67%
- Op Income
- $-1,276,079
- FCF YoY
- 89.52%
Performance & Tape
- 52W High
- $0.14
- 52W Low
- $0.03
- 50D MA
- $0.04
- 200D MA
- $0.05
- Beta
- 1.05
- Avg Volume
- 1.44K
Get TickerSpark's AI analysis on TBRIF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our TBRIF Coverage
We haven't published any research on TBRIF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TBRIF Report →